For more complex molecules such as polyampholytes the pI is the average of the pKa values that represent the boundaries of the zwitterionic form of the molecule. The pI value, like that of pK, is very informative as to the nature of different molecules. A molecule with a low pI would contain a predominance of acidic groups, whereas a high pI indicates predominance of basic groups.
back to the top
Solvation and Hydration shells
Depending on the pH of a solution, macromolecules such as proteins which contain many charged groups, will carry substantial net charge, either positive or negative. Cells of the body and blood contain many polyelectrolytes (molecules that contain multiple same charges, e.g. DNA and RNA) and polyampholytes that are in close proximity. The close association allows these molecules to interact through opposing charged groups. The presence, in cells and blood, of numerous small charged ions (e.g. Na+, Cl-, Mg2+, Mn2+, K+) leads to the interaction of many small ions with the larger macroions. This interaction can result in a shielding of the electrostatic charges of like-charged molecules. This electrostatic shielding allows macroions to become more closely associated than predicted based upon their expected charge repulsion from one another. The net effect of the presence of small ions is to maintain the solubility of macromolecules at pH ranges near their pI. This interaction between solute (e.g. proteins, DNA, RNA, etc.) and solvent (e.g. blood) is termed solvation or hydration. The opposite effect to solvation occurs when the salt (small ion) concentration increases to such a level as to interfere with the solvation of proteins by H2O. This results from the H2O forming hydration shells around the small ions.
back to the top
Role of the Kidneys in Acid-Base Balance
The kidneys function to filter the plasma that passes through the nephrons. Filtration of the plasmas occurs in the glomerular capillaries of the nephron. These capillaries allow the passage of water and low molecular weight solutes (less than 70 kDa) into the capsular space. The filtrate then passes through the proximal and distal convoluted tubules where reabsorption of water and many solutes takes place. In the course of glomerular filtration and tubule reabsorption the composition of the plasma changes generating the typical composition of urine. From a biochemical standpoint the kidneys serve important roles in the regulation of plasma acid-base balance and the elimination of nitrogenous wastes.
back to the top
Sodium Bicarbonate Reabsorption
Regulation of plasma acid-base balance is primarily effected within the kidney through control over HCO3- reabsorption and secretion of H+. Secretion of H+, in excess of its capacity to react with HCO3- in the tubular lumenal fluid, requires the presence of other buffers (see below). The generation of HCO3- and H+ occurs by dissociation of carbonic acid (H2CO3), formed in the tubule cells from H2O and CO2, through the action of carbonic anhydrase. Secretion of H+ into the lumen of the tubule is accompanied by an exchange for Na+. This reabsorption of Na+ occurs by an antiport mechanism during the exchange for H+. Reduction in the intracellular concentration of Na+ occurs by an active transport process involving a Na+/K+-ATPase pump which pumps the excess Na+ into the interstitial fluid. The intracellular HCO3- then diffuses from the tubule cell into the interstitial fluid.
The capacity of the kidney to secrete H+ is regulated by the maximal H+ gradient that can form between the tubule and lumen and still allow transport mechanisms to operate. This gradient is determined by the pH of the urine which in humans is near 4.5. The capacity to secrete H+ would be rapidly reached if it were not for the presence of buffers within the interstitial fluid. The H+ secreted into the tubular lumen can undergo three different fates depending upon the concentration of the three primary buffers of the interstitial fluid. These buffers are HCO3-, HPO42- and NH3. Reaction of H+ with HCO3- forms H2O and CO2 which diffuse back into the tubule cell. The net result of this process is the regeneration of HCO3- within the tubule cell. This process is termed reabsorption of sodium bicarbonate. The reabsorption of sodium bicarbonate takes place primarily within the proximal convoluted tubules.
back to the top
Excretion of Acid
As the concentration of HCO3- in the tubular lumen drops the pH of the fluid drops due to an increasing concentration of H+. The pH of the tubular fluid gradually approaches the pKa for the dibasic/monobasic phosphate buffering system (pKa = 6.8). The excess H+ reacts with dibasic phosphate (HPO42-) forming monobasic phosphate (H2PO4-). The H2PO4- so formed is not reabsorbed and its excretion results in the net excretion of H+. The greatest extent of H2PO4- formation occurs within the distal convoluted tubules and the collecting ducts.
back to the top
Ammonia Secretion
Buffering of H+ is also accomplished by reaction with ammonia, NH3, to form ammonium ion, NH4+. Elimination of NH4+ is the major contributory factor in the ability of the body to excrete acid. Because the pKa of NH4+ is 9.3, excretion of acid in this form can be accomplished without lowering the pH of the urine. Additionally important is the fact that excretion of acid in the form of NH4+ occurs without depleting Na+ nor K+.
Two principal reactions within tubule cells result in the generation of NH3, conversion of glutamine to glutamate and conversion of glutamate to a-ketoglutarate. These reactions are catalyzed by glutaminase and glutamate dehydrogenase, respectively (Equations 21 and 22).
Glutamine ------> Glutamate + NH4+ Eqn. 21
Glutamate -------> a-Ketoglutarate + NH4+ Eqn. 22
Both of these enzymes are abundant in tubule cells. Ammonia is lipid soluble and will diffuse down its concentration gradient out of the tubule cell into the tubular fluid. There it reacts with H+ to yield NH4+ which is excreted in the urine.
back to the top
Neurotoxicity of Ammonia
Excess ammonia is severely neurotoxic. Marked brain damage is seen in cases of failure to make urea via the urea cycle or to eliminate urea through the kidneys. The result of either of these events is a buildup of circulating levels of ammonium ion. Aside from its effect on blood pH, ammonia readily traverses the brain blood barrier and in the brain is converted to glutamate via glutamate dehydrogenase, depleting the brain of a-ketoglutarate. As the a-ketoglutarate is depleted, oxaloacetate falls correspondingly, and ultimately TCA cycle activity comes to a halt. In the absence of aerobic oxidative phosphorylation and TCA cycle activity, irreparable cell damage and neural cell death ensue.
back to the top
Acidosis and Alkalosis
The kidneys play an important role in the control of acidosis by responding with an increase in the excretion of H+. When H+ is excreted as a titratable acid such as H2PO4- or when the anions of strong acids such as acetoacetate are excreted there is a requirement for simultaneous excretion of cations to maintain electrical neutrality. The principal cation excreted is Na+. As the level of excretable Na+ is depleted excretion of K+ increases. In conditions of acidosis the kidney will increase the production of NH3 from tubular amino acids or amino acids absorbed from the plasma. As indicated the NH3 can diffuse across the tubule cell membrane where it will react with H+ to form the excretable ammonium ion without a concomitant requirement for cation excretion. This demonstrates that an inability of the kidney to generate NH3 would rapidly lead to fatal acidosis.
When the kidneys fail to modulate HCO3- excretion, metabolic alkalosis will develop. Alkalosis is normally countered quite effectively by the kidney allowing HCO3- to freely escape. Alkalosis generally only becomes problematic if the kidneys are restricted in their ability to secrete HCO3-. This situation can occur in patients taking diuretics since several of this class of drug cause a reduction in the ability of the kidney to reabsorb an anion (e.g. Cl-) concomitant with the reabsorption of Na+.
back to the top
Return to Medical Biochemistry Page
Michael W. King, Ph.D / IU School of Medicine / mking@medicine.indstate.edu
Last modified: Thursday, 10-May-01 10:12:52